Serimmune

Biotechnology company focused on mapping human immunity through its SERA (Serum Epitope Repertoire Analysis) platform, which comprehensively profiles the antibody response to infections, vaccines, and autoimmune conditions.

Location
Santa Barbara, California, USA
Founded
2016
Investors
1
Categories
immunology, biomarkers, biotech, diagnostics, infectious-disease

Investors

NameLocationTypeStagesPortfolio
Illumina VenturesSan Francisco, California, USAbiotech-focused
seedseries-a+1
32